FOLLI, FRANCO
FOLLI, FRANCO
Dipartimento di Scienze della Salute
Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in islets of Langerhans: implications for type 2 diabetes pathogenesis
2024 A. Galli, S. Moretti, N. Dule, E.S. Di Cairano, M. Castagna, P. Marciani, C. Battaglia, F. Bertuzzi, I. Pastore, P. Fiorina, S. La Rosa, A. Davalli, F. Folli, C. Perego
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide
2024 M.E. Lunati, V. Cimino, D. Bernasconi, A. Gandolfi, P.S. Morpurgo, C. Tinari, E. Lazzaroni, L. Baruffaldi, M. Muratori, L. Montefusco, I. Pastore, A. Rossi, I.G. Franzetti, F. Muratori, R. Manfrini, O.E. Disoteo, R. Terranova, P. Desenzani, A. Girelli, R. Ghelardi, F. D'Addio, M. Ben Nasr, C. Berra, F. Folli, L. Bucciarelli, P. Fiorina
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
2023 S. Piccini, G. Favacchio, C. Panico, E. Morenghi, F. Folli, G. Mazziotti, A.G. Lania, M. Mirani
Delayed puberal development in obese males: possible role of hypogonadotropic hypogonadism
2023 F. Pecori Giraldi, M. Mancini, F. Diana, I.A. Matelloni, A. Rossi, M. Tosi, F. Folli
Beneficial effects on anthropometric and metabolic parameters in overweight and obese boys after 1 year nutritional-behavioral intervention
2023 M. Tosi, I.A. Matelloni, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi, F. Folli
Metformin acts in the gut and induces gut-liver crosstalk
2023 N. Tobar, G.Z. Rocha, A. Santos, D. Guadagnini, H.B. Assalin, J.A. Camargo, A.E.S.S. Gonçalves, F.R. Pallis, A.G. Oliveira, S.A. Rocco, R.M. Neto, I.L. de Sousa, M.R. Alborghetti, M.L. Sforça, P.B. Rodrigues, R.G. Ludwig, E.C. Vanzela, S.Q. Brunetto, P.A. Boer, J.A.R. Gontijo, B. Geloneze, C.R.O. Carvalho, P.O. Prada, F. Folli, R. Curi, M.A. Mori, M.A.R. Vinolo, C.D. Ramos, K.G. Franchini, C.F. Tormena, M.J.A. Saad
Multiple beneficial effects of 1-year nutritional-behavioral intervention on anthropometric and metabolic parameters in overweight and obese boys
2023 M. Tosi, I.A. Matelloni, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi, F. Folli
Beneficial effects on anthropometric and metabolic parameters in overweight and obese boys after 1 year nutritional-behavioral intervention
2023 F. Folli, M. Tosi, I.A. Matelloni, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi
Effetti benefici su parametri antropometrici e metabolici in ragazzi in sovrappeso e obesi dopo un intervento nutrizionale-comportamentale di un anno
2023 M. Tosi, I.A. Matelloni, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi, F. Folli
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users
2023 M.J. Shram, J.E. Henningfield, G. Apseloff, C.W. Gorodetzky, S. De Martin, F.L. Vocci, F.L. Sapienza, T.R. Kosten, J. Huston, A. Buchhalter, J. Ashworth, R. Lanier, F. Folli, A. Mattarei, C. Guidetti, S. Comai, C. O’Gorman, S. Traversa, C.E. Inturrisi, P.L. Manfredi, M. Pappagallo
Drug–Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism
2023 N. Ferri, S. De Martin, J. Stuart, S. Traversa, F. Folli, M. Pappagallo, C. O'Gorman, C. Guidetti, A. Mattarei, C.E. Inturrisi, P.L. Manfredi
Effetti benefici sui parametri antropometrici e metabolici nei ragazzi sovrappeso e obesi dopo 1 anno di intervento nutrizionale-comportamentale
2023 I.A. Matelloni, M. Tosi, M. Mancini, A. Andreassi, A. Scopari, A. Rossi, E. Verduci, C. Berra, R. Manfrini, G. Banderali, F. Pecori Giraldi, F. Folli
Alanine transferase levels (ALT) and triglyceride-glucose index are risk factors for type 2 diabetes mellitus in obese patients
2023 F. Folli, A.E. Pontiroli, A.S. Zakaria, L. Centofanti, E. Tagliabue, L. La Sala
AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus
2023 C. Berra, R. Manfrini, M. Mirani, L. Bucciarelli, A.S. Zakaria, S. Piccini, R. Ghelardi, M.E. Lunati, S. Rodovalho, F. Bifari, P. Fiorina, F. Folli
Effect of Prolonged and Substantial Weight Loss on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis
2023 A.E. Pontiroli, L. Centofanti, C. Le Roux, S. Magnani, E. Tagliabue, F. Folli
Esmethadone-HCl (REL-1017): a promising rapid antidepressant
2023 M. Fava, S.M. Stahl, S. De Martin, A. Mattarei, E. Bettini, S. Comai, A. Alimonti, F. Bifari, L. Pani, F. Folli, C. Guidetti, A. Furlan, J. Sgrignani, P. Locatelli, A. Cavalli, C. O'Gorman, S. Traversa, C.E. Inturrisi, M. Pappagallo, P.L. Manfredi
Mechanisms of action of incretin receptor based dual- and tri-agonists in pancreatic islets
2023 F. Folli, G. Finzi, R. Manfrini, A. Galli, F. Casiraghi, L. Centofanti, C. Berra, P. Fiorina, A. Davalli, S. La Rosa, C. Perego, P.B. Higgins
Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis
2023 F. Folli, L. Centofanti, S. Magnani, E. Tagliabue, M. Bignotto, L. La Sala, A.E. Pontiroli
Uno studio longitudinale sull’incidenza di eventi cardiovascolari in una popolazione del nord Italia
2022 E. Bianco, M. Dei Cas, M. Bignotto, C. Morano, C. Rigoldi, G. Trevisi, C. Berra, P. Zermiani, M. Zuin, R. Paroni, F. Folli, P. Battezzati
Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes
2022 F. D'Addio, G. Sabiu, V. Usuelli, E. Assi, A. Abdelsalam, A. Maestroni, A. Joe Seelam, M. Ben Nasr, C. Loretelli, D. Mileto, G. Rossi, I. Pastore, L. Montefusco, P.S. Morpurgo, L. Plebani, A. Rossi, E. Chebat, A.M. Bolla, E. Lunati, C. Mameli, M. Macedoni, S. Antinori, S. Rusconi, M. Gallieni, C. Berra, F. Folli, M. Galli, M. Rita Gismondo, G. Vincenzo Zuccotti, P. Fiorina